Skip to content

Efficacy of Chemical peeling versus Cryotherapy in the Treatment of Solar Lentigo

Efficacy and Side Effects of Trichloroacetic Acid (TCA) versus Cryotherapy in the Treatment of Solar Lentigo

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT138904084269N1
Enrollment
35
Registered
2010-10-09
Start date
2008-10-15
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solar lentigo. other melanin hyperpigmentation

Interventions

Intervention 1: After washing with water and soap, the lesion was treated with TCA 35% with a cotton applicator. Intervention 2: Cryotherapy spray for one time so that tip of the spray had a 3-centime
Treatment - Drugs
Treatment - Other
After washing with water and soap, the lesion was treated with TCA 35% with a cotton applicator
Cryotherapy spray for one time so that tip of the spray had a 3-centimeter distance with the lesion and spraying was continued until surface of the lesion became frosted as a result of spraying. Durat

Sponsors

Research Vice-chancellor of Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: solar lentigo of face or hand Exclusion criteria: wart, recurrent herpes, sensitivity to light, raynaud phenomenon, pregnancy, lactation, sunburn within recent 2-3 days, those who have received treatments such as surgery, cryotherapy, radiotherapy or PUVA therapy within the last 6 weeks or Isotretinoin during last 6 months

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Lightening of lesions. Timepoint: 2 months after treatment. Method of measurement: clinical.

Secondary

MeasureTime frame
Side effects: Permanent & severe pain, Blister, Permanent erythema & edema, hyperpigmentation, hypopigmentation, scar. Timepoint: Every month. Method of measurement: clinical.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Farideh Golfroushan

Tabriz University of Medical Sciences

Dr_fGolfroushan@yahoo.com+98 914 315 5647

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026